HOME >> BIOLOGY >> NEWS
Ingredient in garlic protects against severe chronic pulmonary hypertension in rats

Small daily doses of allicin, the active metabolic in garlic, proved effective in preventing a severe form of pulmonary hypertension in rats, according to a study reported Saturday, April 2 by University of Alabama at Birmingham researchers at the Experimental Biology 2005 meeting in San Diego. The human form of the disease primary pulmonary hypertension often leads to cardiovascular complications such as right heart hypertrophy and failure and is frequently lethal.

Dr. David D. Ku says the findings confirm an earlier study by the team that garlic protects against a less lethal form of acute pulmonary hypertension in rats. The new study by Ku, graduate student Hsien Chin Wu and research assistant Xiaowei Sun, not only looks at a chronic form of the disease but also goes a big step further by pinpointing the effective ingredient in garlic and demonstrating that it achieves its protective effects through vasorelaxation.

The presentation at Experimental Biology 2005 was part of the scientific sessions of the American Society for Pharmacology and Experimental Therapeutics.

In the UAB study, rats were given a single dose of monocrotaline, a well-established mechanism for inducing vasoconstriction of the pulmonary arteries. Within three weeks, half the rats had developed chronic pulmonary hypertension, with markedly increased pulmonary arterial pressure, just as expected. But the other half experienced no such increase. These rats had received the hypertension-causing drug but their diets also had been supplemented daily for three weeks with small doses of allicin. And it was the allicin, not the garlic itself that protected the supplemented rats from developing the disease, emphasizes Dr. Ku. Animals that consumed garlic from which the active metabolite had been removed or inactivated with heat experienced no benefit.

In a separate but related study also presented at Experimental Biology 2005, in the scientific sessions of the Amer
'"/>

Contact: Sarah Goodwin
ebpress@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
2-Apr-2005


Page: 1 2 3

Related biology news :

1. Ingredient in Big Macs and sodas can stabilize
2. Ingredient in Prozac increases risk of extinction for freshwater mussels
3. Vampires beware: Scripps scientists describe molecular basis of raw garlics pungency
4. Activation of thermoreceptors mediates raw garlics burning pungency
5. Reading ability protects brain from lead exposure
6. Research shows NPD1 protects a key component of vision
7. Drug protects brain cells in Huntingtons disease model, researchers find
8. A gene that protects from kidney disease
9. PINK1 protects from Parkinsons
10. Enzyme delivered in smaller package protects cells from radiation damage
11. Parkinsons protein protects neurons from stress induced cell death

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 04, 2019 , ... ... has launched Subnovii Advanced Plasma Technology for U.S. dermatologists, plastic surgeons ... is the only plasma to employ LF technology – low frequency plus a ...
(Date:11/27/2019)... ... November 26, 2019 , ... Smile ... Ellyn, IL practice for Invisalign® treatment. Invisalign orthodontics uses a series ... a misaligned bite, also known as malocclusion, present both functional and cosmetic concerns. ...
(Date:11/22/2019)... ... November 21, 2019 , ... The inventors of a new ... a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals ... off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... 2020 , ... COBO Technologies and Cardea Bio partner to ... agreed to co-develop and market a portfolio of CRISPR QC products and services ... longer-term, the parties aim to develop a COBO branded QC device based on ...
(Date:1/10/2020)... (PRWEB) , ... January 09, 2020 , ... ... of Drug Development establishes benchmarks for the vendor qualification process, a critical ... Report, the process volume and complexity of the vendor qualification process creates delays ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... announced its inaugural GenScript Biotech Global Forum on Jan. 14 in San Francisco, ... "Cell and Gene Therapy and the Booming China Market," will feature gene and ...
(Date:1/8/2020)... ... 2020 , ... RMA of Connecticut , a leading ... family, has announced that five of their Board-Certified reproductive endocrinologists have been honored ... publishing company Castle Connolly has compiled the list of America’s Top ...
Breaking Biology Technology:
Cached News: